Pharmaceutical Sector

Dr. Reddy’s Q1 net profit dips 26%

The net profit of Dr. Reddy’s Laboratories fell down by 26 per cent in Q1 of the exiting fiscal. This fall is noticed due to increase in selling and general and administrative expenses suffered by company for the period of Q1.

Bilcare, Meadwestvaco to acquire US-based International Labs

Pune-based Bilcare along with US-based Meadwestvaco Corporation have jointly acquired International Labs, a Florida-based pharmaceutical packaging company, for an undisclosed amount.  

Celestial Labs Acquires Channel Partnership Of Microsoft, Stock Surges 8%

Celestial Labs, leading developer of biopharmaceuticals and industrial enzymes, has acquired the channel partnership of Microsoft to strengthen its ERP business.

Sun Pharma extends offer for Taro till Sept 2

The tender offer, which was put forward by Sun Pharmaceutical Industries Sun Pharma extends offer for Taro till Sept 2

Ranbaxy Intraday Buy Call

Karvy Stock Broking Limited has maintained ‘Buy’ rating on Ranbaxy Laboratories stock with an intraday target of Rs 430.

Ranbaxy shares dip 11% over US probe

Shares of Ranbaxy Laboratories Ltd witnessed the biggest fall in past Ranbaxy shares dip 11% over US probe

Pages